Gyre Therapeutics, Inc. Accrued Employee Benefits, Current
Gyre Therapeutics, Inc. (GYRE) had Accrued Employee Benefits, Current of $708.00 thousand as of 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Notes
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2023-10-26
- 2023-09-30: Accrued Employee Benefits, Current $708.00K.
- 2023-06-30: Accrued Employee Benefits, Current $720.00K.
- 2023-03-31: Accrued Employee Benefits, Current $1.08M.
- 2022-12-31: Accrued Employee Benefits, Current $2.58M.
| Period end | Accrued Employee Benefits, Current | Accrued Employee Benefits, Current as first filed |
|---|---|---|
| 2023-09-30 | $708.00K 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $720.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.08M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.58M 10-Q · filed 2023-10-26 | |
| 2022-09-30 | $1.04M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $911.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.14M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.47M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $2.55M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.52M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.23M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.48M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.54M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.78M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.27M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.11M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $1.58M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.41M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $876.00K 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $1.50M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $1.08M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $897.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $511.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $1.37M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $920.00K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $676.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $645.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $596.00K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $682.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $682.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $619.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $926.00K 10-K · filed 2017-03-08 | |
| 2015-09-30 | $823.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $486.00K 8-K/A · filed 2015-10-23 | |
| 2014-12-31 | $281.00K 10-K · filed 2016-03-09 | $280.73K 8-K/A · filed 2015-10-23 |
| 2013-12-31 | $233.92K 8-K/A · filed 2015-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |